Did anyone listen in live to the conference call and try and ask...

Did anyone listen in live to the conference call and try and ask a question? Just odd that with so many retail holders only 7 questions asked and all for broker analysts ? Not sure they were dorothy dixers but were very mild and didn't even ask which geographic region had the odd results and if those results were high for the control and low for HA-I . Had they all been pre-briefed between announcement and conference call? To hear one ask about previous trial and confirm details that have been in black and white for years was most odd and a worry if you were reading their newsletter or advice? Not a single follow up after dry answers bar the bombshell " we had the results from Thursday 2am" . . That was a odd comment as they were obviously expecting them to note it was 2am and then we had a odd trading day Thursday as well.

Did the HA-I arm have lower side affects that would enable a higher dose?